The Food and Drug Administration in the past several months has employed a broad array of tools-consent decree, drug seizures and 68 warning letters about products used to treat influenza A (H1N1) in its efforts to accelerate its stricter enforcement campaign within the pharmaceutical industry according to Edwin Rivera-Martinez, Chief of the International Compliance Branch in CDER Division of Manufacturing and Compliance.To view article visit: www.fdanews.com.
Posts
No comments:
Post a Comment